Brief: Gt Biopharma Reports Q3 Fiscal 2022 Results
31/10/2022 21:20
Oct 31 (Reuters) - GT Biopharma Inc GTBP.O :
* GT BIOPHARMA REPORTS THIRD QUARTER FISCAL 2022 FINANCIAL
RESULTS
AND BUSINESS UPDATE
* GT BIOPHARMA - $20.8 MILLION IN CASH, CASH EQUIVALENTS,
SHORT-TERM INVESTMENTS AS OF SEPT 30, IS EXPECTED TO PROVIDE
RUNWAY TO FUND OPERATIONS INTO 2023
* GT BIOPHARMA INC - QTRLY LOSS PER SHARE $0.22
Source text for Eikon: ID:nGNX9cBNq2
Further company coverage: GTBP.O
((Reuters.Briefs@thomsonreuters.com;))